Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclear inositol lipid cycle and differentiation

L Cocco1, A M Martelli, S Capitani

  • 1Institute of Human Anatomy, University of Bologna, Italy.

Advances in Enzyme Regulation
|January 1, 1995
PubMed
Summary

Nuclear phosphoinositide signaling plays a role in cell differentiation. Specifically, PLC beta 1 is down-regulated during erythroleukemia cell differentiation, impacting the intranuclear inositide cycle.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diet Modulation Restores Autophagic Flux in Damaged Skeletal Muscle Cells.

The journal of nutrition, health & aging·2019
Same author

INPP4B overexpression and c-KIT downregulation in human achalasia.

Neurogastroenterology and motility·2018
Same author

Therapeutic targeting of CK2 in acute and chronic leukemias.

Leukemia·2017
Same author

Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.

Leukemia·2016
Same author

Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis.

Leukemia·2014
Same author

Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia.

Leukemia·2013

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • An autonomous intranuclear inositide cycle exists, involving lipid kinases and phospholipase C (PLC).
  • The PLC beta 1 isoform is typically found in various cell types and activated by IGF-I in Swiss 3T3 cells.
  • Nuclear inositol lipid cycle behavior was investigated in Friend erythroleukemia cells.

Purpose of the Study:

  • To investigate the nuclear inositol lipid cycle in Friend erythroleukemia cells.
  • To determine the role of specific PLC isoforms during erythroid differentiation.
  • To understand the impact of differentiating agents on the intranuclear inositide cycle.

Main Methods:

  • Utilized immunochemical and immunocytochemical analyses.
  • Determined enzymatic activity directly.

Related Experiment Videos

  • Employed neutralizing monoclonal antibodies and Northern blot analysis for PLC beta 1.
  • Investigated nuclei from Friend erythroleukemia cells treated with differentiating agents (DMSO, tiazofurin).

    • Main Results:

    • Friend erythroleukemia cell nuclei possess both lipid kinases and PLC.
    • Treatment with differentiating agents led to polyphosphoinositide accumulation and decreased DAG.
    • Down-regulation of a specific PLC isoform was observed during differentiation.
    • While both PLC beta 1 and gamma 1 isoforms are present, only PLC beta 1 expression and activity decreased during erythroid differentiation.

    Conclusions:

    • Nuclear PLC beta 1 activity and expression are down-regulated during erythroleukemia cell differentiation.
    • This suggests a role for nuclear phosphoinositide signaling in cell differentiation processes.
    • Nuclear PLC beta 1 is identified as a crucial component in the erythroid differentiative commitment of murine erythroleukemia cells.